Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
BNTC compared with CTNM: revenue, margins and what each company keeps, and the suppliers and customers both name
BNTC
Benitec Biopharma Inc.
Change
Mkt cap
Revenue
Revenue
CTNM
Contineum Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
BNTC
Benitec Biopharma Inc.
vs
CTNM
Contineum Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only BNTC
2
—
Australian government
unlisted
supplier
—
Axovant Therapeutics
unlisted
customer
Shared
0
No shared counterparties.
Only CTNM
2
JNJ
J&J
customer
—
WuXi AppTec
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
BNTC
Benitec Biopharma Inc.
Change
8.67
▲
+2.12%
Mkt cap
$304.9M
Revenue
$7,000
Q4 FY23
CTNM
Contineum Therapeutics, Inc.
Change
9.82
▲
+2.70%
Regular session
Nov 3 '26
Mkt cap
$359.7M
Revenue
—
vs
Compare
Regular session
Nov 3 '26
BNTC
Benitec Biopharma Inc.
vs
CTNM
Contineum Therapeutics, Inc.
8.67
▲
+2.12%
Price
9.82
▲
+2.70%
$304.9M
Mkt cap
$359.7M
Q4 FY23
$7,000
Revenue
—
Change
Change
BNTC
8.67
▲
+2.12%
vs
CTNM
9.82
▲
+2.70%
Regular session
Nov 3 '26